Clinical Trial Update: Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction therapy with panitumumab plus mFOLFOX-6 in rectal cancer prior to surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)
• mFOLFOX-6

Snippet

Sponsor: Grupo Espanol Multidisciplinario del Cancer Digestivo | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED